This inventor holds 1 USPTO granted patent. Top assignee: Zealand Pharma A/s. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Søren Neve: Innovator in Peptide Therapeutics
Introduction
Søren Neve is a prominent inventor based in Lyngby, Denmark. He has made significant contributions to the field of peptide therapeutics, particularly in the development of novel treatments for managing blood glucose levels.
Latest Patents
Søren Neve holds a patent for "Peptide agonists of GLP-1 activity." This invention relates to novel peptide conjugates that exhibit increased stability and are beneficial in treating excess levels of blood glucose. His innovative approach has the potential to improve the lives of individuals with diabetes.
Career Highlights
Søren Neve is associated with Zealand Pharma A/S, a company known for its focus on developing innovative peptide-based medicines. His work at Zealand Pharma has positioned him as a key player in the biotechnology sector, contributing to advancements in therapeutic solutions.
Collaborations
Some of his notable coworkers include Bjarne Due Larsen and Jens Damsgaard Mikkelsen. Their collaborative efforts have further enhanced the research and development initiatives at Zealand Pharma.
Conclusion
Søren Neve's contributions to peptide therapeutics exemplify the impact of innovative thinking in medicine. His work continues to pave the way for new treatments that address critical health challenges.